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Abstract
Background: Wildland firefighters conducting prescribed burns are exposed to a complex 
mixture of pollutants, requiring an integrated measure of exposure.
Objective: We used urinary mutagenicity to assess if systemic exposure to mutagens are higher 
in firefighters after working at prescribed burns versus after non-burn work days. Other biomarkers 
of exposure and oxidative stress markers were also measured.
Methods: Using a repeated measures study design, we collected urine before, immediately after, 
and the morning after a work shift on prescribed burn and non-burn work days from 12 healthy 
subjects. Urines were analyzed for malondialdehyde (MDA), 8-isoprostane, 1-hydroxypyrene 
(OH-Pyrene), and mutagenicity in Salmonella YG1041 +S9. Particulate matter (PM2.5) and carbon 
monoxide (CO) measurements were collected by personal monitoring. Light-absorbing carbon 
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(LAC) of PM2.5 was measured as a surrogate for black carbon exposure. Linear mixed-effect 
models were used to assess cross-work shift (pre- to post-work shift) changes in urinary 
biomarkers.
Results: No significant differences occurred in creatinine-adjusted urinary mutagenicity across 
the work shift between burn days (48 samples) and non-burn day (21 samples). Firefighters 
lighting fires had a non-significant, 1.6-fold increase in urinary mutagenicity for burn- versus non-
burn day exposures. Positive associations were found between cross-work shift (pre- to post-) 
changes in creatinine-adjusted urinary mutagenicity and MDA (p = 0.0010), OH-Pyrene (p = 
0.0001), and mass absorption efficiency, which is the LAC/PM2.5 ratio (p = 0.2245), respectively. 
No significant effect of day type or work task on cross-work shift (pre- to post-) changes in MDA 
or 8-isoprostane was observed.
Conclusion: Urinary mutagenicity may serve as a suitable measure of occupational smoke 
exposures among wildland firefighters, especially among those lighting fires for prescribed burns.
INTRODUCTION
Extensive studies show that smoke from wildland fires is associated with increased 
respiratory and cardiovascular disease among the general public (Adetona O et al. 2016; 
Reid et al. 2016; Black et al. 2017; Cascio 2018). Wood smoke alone is composed of 
hundreds of constituents, many of which are mutagenic and carcinogenic (Naeher et al. 
2007). There has been only one study of the mutagenicity of smoke from a wildland fire, and 
organic extracts of particulate matter <10 μm in diameter (PM10) in which such fires in the 
Brazilian Amazon were found to be highly mutagenic in aSalmonella mutagenicity assay (de 
Oliveira Galvão et al. 2018). In addition, the International Agency for Research on Cancer 
(IARC) has classified the household combustion of biomass (primarily wood) as a probable 
(Group 2A) human carcinogen (IARC 2010).
Prescribed burning is a special category of wildland firefighting that involves the preplanned 
lighting of fires under the direction of certified management, usually for the prevention of 
wildland fires or to inhibit the advance of such fires, and these fires also can produce 
environmental and health impacts (Haikerwal et al. 2015; Adetona O et al. 2016). 
Individuals initiating prescribed burns may experience exposures in addition to wood smoke, 
such as emissions from drip-torches fueled by a mixture of diesel and gasoline (Adetona O 
et al. 2016). Diesel and gasoline emissions are also mutagenic and are classified, 
respectively, as known (Group 1) or possible (Group 2B) human carcinogens (IARC 2014). 
Although protective clothing is worn, wildland firefighters are not protected from inhalation 
exposures and typically do not wear protective masks, unlike municipal firefighters who use 
self-contained breathing apparatuses (SCBAs) with supplied fresh air.
Many studies document the elevated exposure of wildland firefighters to potential mutagens 
based on concentrations of hydroxylated urinary metabolites of polycyclic aromatic 
hydrocarbons (OH-PAHs) (Adetona O et al. 2016; Keir et al. 2017). Studies involving 
charcoal workers or people using wood-fired steam baths (temazcales) have also found that 
exposure to such wood smoke results in mutagenic urine, indicative of a systemic exposure 
to mutagenic and potentially carcinogenic compounds (Kato et al. 2004a; Long et al. 2014). 
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Although there is a recent report showing elevated urinary mutagenicity in municipal 
firefighters (Keir et al. 2017), no such study is reported for wildland firefighters. The 
purpose of this pilot study was to evaluate systemic genotoxicity in wildland firefighters 
exposed to smoke from wood and/or diesel/gasoline fuel exhaust before and after a 
prescribed burn through the assessment of urinary mutagenicity in theSalmonella (Ames) 
mutagenicity assay.
Urinary mutagenicity provides an integrated measure of exposure to complex mixtures of 
genotoxic pollutants (Černá et al. 1997). Previous studies have found that urinary 
mutagenicity correlates with other biomarkers in subjects exposed to wood smoke as well as 
a variety of other pollutants, including benzidine dyes, cigarette smoke, heterocyclic amines, 
and nitrotoluenes (Černá et al. 1997; DeMarini et al. 1997; Kato et al. 2004b; Sabbioni et al. 
2006; Shaughnessy et al. 2011; Long et al. 2014). Therefore, we explored the relationship 
between urinary mutagenicity, a variety of personal occupational exposure measurements, 
and urinary OH-PAHs among wildland firefighters at prescribed burns. Because air pollution 
exposure may lead to increased body burden of oxidative stress, (IARC 2016) we also 
measured urinary concentrations of two common biomarkers of oxidative stress, 
malondialdehyde (MDA) and 8-isoprostane, and we explored the relationships between each 
of these biomarkers and urinary mutagenicity.
We hypothesized that urinary mutagenicity would be significantly higher among firefighters 
after working at prescribed burns (post-work shift levels) compared to pre-work shift levels 
and compared to non-burn work days. We also hypothesized that work task would impact 
urinary mutagenicity, with firefighters lighting fires with diesel-gasoline-fueled drip-torches 
having higher urinary mutagenic potency compared to those performing other work tasks.
METHODS
Study Population and Design
Twelve healthy subjects (ten wildland firefighters and two work-certified volunteers) with 
the United States Department of Agriculture Forest Service at Savannah River Site (USFS-
Savannah River), South Carolina, were monitored for occupational exposures during their 
work shifts at prescribed burns and on working days when prescribed burns were not 
conducted during January-July of 2015. Before and after-work-shift, spot urine samples 
were collected each sampling day. This study was approved by the University of Georgia 
Institutional Review Board, and written informed consent was obtained from each subject 
before their voluntary participation.
Baseline questionnaires and daily work activity questionnaires were administered to subjects 
to gain information on personal work history, length of firefighter career, health habits (i.e. 
exercise frequency, tobacco use), disease history, medication, diet (i.e. grilled-foods), daily 
work tasks, and other factors that could be considered influences on exposure and/or on 
mutagenic responses.
Subjects’ self-reported work tasks were categorized into four major categories, two of which 
were on burn days (“Holding” and “Lighting”), and two on non-burn work days (“Non-burn 
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day—Exposures” and “Non-burn day—Office”). On burn days, work tasks included holding 
prescribed fire-lines (subjects were referred to as “Holders”) where firefighters used fire 
engine vehicles to patrol and contain fires from escaping established boundaries, and 
lighting (herein subjects were referred to as “Lighters”) frequently by hand using a drip-
torch or less often by aerial methods (i.e. helicopter). Subjects also conducted various tasks 
on non-burn workdays, which included patrolling of areas where recent burns were 
conducted, field prep work, engine maintenance, etc. These tasks were all classified as 
“Non-burn day—Exposures” because subjects reported experiencing occupational exposures 
to vehicle exhaust, diesel, dust, or possible exposures to smoke from smoldering when 
patrolling areas where recent burns were conducted. Non-burn workdays also included 
subjects performing office work. An assigned primary work task was determined by reported 
time spent during a specific work task, i.e., the subject had spent more than 50% of the 
duration of a work-shift conducting the task.
Urine Sample Collection
Subjects were instructed on how to properly collect their urine samples in sterile 
polypropylene 4.5-ounce (~133 ml) cups. Spot urine samples were collected immediately 
before a work shift, immediately after a work shift, and the morning-after a work shift. 
Samples were frozen at −5°C immediately after collection and transported on dry ice to a 
−80°C freezer at the University of Georgia, Department of Environmental Health Science. 
The samples were thawed once to room temperature to prepare randomized aliquots into 
sterile, polypropylene, conical 50-ml tubes and again stored at −80°C until further analyses. 
All urine samples were analyzed in a blinded fashion.
Occupational Exposure Assessment
Gravimetric particulate matter with an aerodynamic diameter of ≤ 2.5 μm (PM2.5) and 
carbon monoxide (CO) were measured in the breathing zone of the subjects on burn and 
non-burn work days. The subjects did not use respiratory protection during the study. A 
detailed description of the sample collection methods and gravimetric analyses were 
reported previously (Adetona AM 2016) In brief, all exposure monitoring instruments were 
calibrated prior to use, and gravimetric analyses followed the United States Environmental 
Protection Agency (U.S. EPA) specifications (U.S. Environmental Protection Agency. Field 
Standard Operating Procedures for the PM2.5 Performance Evaluation Program 2006). 
PM2.5 samples were collected using MicroPEM™ (RTI International, Research Triangle 
Park, NC, USA) loaded with 25-mm polytetrafluoroethylene membrane filters (porosity: 3.0 
μm) (Pall Life Sciences, Ann Arbor, MI, USA). Filters were weighed using the Cahn C-35 
microbalance (sensitivity of ±1.0 μg; Thermo Electron, Waltham, MA, USA). All filter 
weights were blank-adjusted as described previously (Adetona AM 2016). After gravimetric 
analyses, PM on the filters was analyzed for light absorbing carbon (LAC) by reflectance 
analysis using the Evans Electroselenium Limited smoke stain reflectometer (Model 43D, 
Diffusion Systems Ltd, London, United Kingdom) as described (Adetona AM 2016), and 
used as a surrogate for black carbon (BC). Absorption coefficients (×10−5m−1) were 
calculated according to ISO 9835, and PM2.5 mass absorption efficiencies (×10−5m2/μg) 
were determined by dividing the absorption coefficients by gravimetric PM2.5 
concentrations. Real-time CO was measured using the Dräger Pac III (DrägerSafety Inc., 
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Pittsburgh, PA, USA). Time-weighted averages were calculated for both PM2.5 (μg/m3) and 
CO (ppm).
Malondialdehyde Analysis
Concentrations of malondialdehyde (MDA) were measured using a High-Performance 
Liquid Chromatography (HPLC) system coupled with a fluorescent detector (Lärstad et al. 
2002). A 150-μl sample was added into a mixture of 750 μl phosphoric acid (440 mM) and 
150 μl thiobarbituric acid (TBA, 42 mM). After 1-h incubation at 80°C, 20 μl of this final 
solution was injected into the HPLC system with the fluorescence detector set at 532 nm for 
the excitation wavelength and 553 nm for the emission wavelength. A Nova-Pak C18 column 
(Waters, Milford, MA, USA) was used with a mobile phase that was composed of 40% 
methanol and 60% water containing 50-mM KH2PO4 (pH = 6.8) at a flow rate of 0.8 ml/
min. The detection limit, extraction recovery, and analytical precision of this method were 
1.8 nM, 75.9%, and 2.2% (measured as relative standard deviation from 8 replicate 
injections), respectively. MDA was presented in nmol/L. Creatinine-adjusted concentrations, 
expressed as μmol MDA per mol creatinine, were calculated to correct for urine dilution. 
Urinary creatinine (mg/dL) was measured by a Beckman Coulter AU Analyzer for 
Creatinine (Beckman Coulter, Inc., Brea, CA, USA).
8-Isoprostane Analysis
Concentrations of 8-isoprostane in urine aliquots were measured using an enzyme linked 
immunosorbent assay kit (15-F2t-isoprostane [8-iso-PGF2α], NW Laboratories, LLC, 
ELISA kits, #NWK-ISO02). Urine samples were run in duplicate, standards were run in 
duplicate or triplicate, and creatinine-adjusted concentrations (μmol 8-isoprostane per mol 
creatinine) were calculated.
1-Hydroxypyrene Analysis
Urine aliquots underwent hydrolysis and solid phase extractions before analysis for OH-
pyrene using an HPLC-fluorescence technique. A full description of the method has been 
reported (Birch 2017). The concentrations were expressed in pg/mL urine metabolite 
concentration and creatinine-adjusted concentrations (μmol OH-Pyrene/mol creatinine).
Sample Extraction and Preparation for Mutagenicity Assay
Organic extracts from the urine samples were prepared as described previously (Kato et al. 
2004b). In brief, urine aliquots were thawed and filtered to remove urothelial cells. The 
volume of each sample was recorded, and the urine was enzymatically de-conjugated in 0.2-
M (10% v/v) sodium acetate buffer (pH 5.0) (Sigma, St. Louis, MO, USA) containing β-
glucuronidase (6 units/ml urine; Sigma, St. Louis, MO, USA) and sulphatase (2 units/ml 
urine, Sigma, St. Louis, MO, USA) for 16 h at 37°C. The de-conjugated urinary metabolites 
were then extracted and concentrated by pouring the urine through two C-18 silica-gel 
columns stacked in tandem (Waters Sep-Pak WAT04305, Milford, MA, USA). The eluted 
urine was discarded, and a new tube was placed under the column to collect the organics, 
which were eluted by pouring 10 ml of methanol through the column. The methanol extract 
was filtered through a 0.22-μm filter and then solvent-exchanged with dimethyl sulfoxide 
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(DMSO) to produce an organic concentrate at 150×. These extracts were stored at 4°C until 
mutagenicity assays were conducted.
Mutagenicity Assay
The Salmonella (Ames) mutagenicity assay was performed using the plate-incorporation 
method (Maron and Ames 1983) to evaluate the organic extracts of the urines in a blinded 
fashion. A detailed description of the assay method has been reported (Kato et al. 2004a; 
Mutlu et al. 2015). Briefly, the urine concentrates were evaluated in seven batch experiments 
at 0.0 and 10.0, 0.0 and 12.0, or 0.0 and 15.0 ml-equivalents of urine/plate (ml-eq/plate) with 
four to seven doses per sample depending on the volume of urine sample available (Note: 
Dosing sometimes varied based on total urine volume available. i.e. 0.0, 0.5, 1.5, 3.0, 7.5, 
12.0 or 15 ml-equivalents of urine/plate; 0.0, 4.0, 6.0, or 10.0 ml-equivalents of urine/plate; 
0.0, 2.25, 4.0, 6.75, 9.0, 12 or 15 ml-eq/plate) in the presence of metabolic activation (S9 
mix) made from Aroclor-induced, Sprague-Dawley rat-liver S9 (Moltox, Boone, NC, USA). 
The concentrate (not exceeding 100 μl of DMSO/plate) was added to 2.5-ml of top agar, 
along with 100 μl of overnight cell suspension, with 500 μl of S9 mix. The contents of the 
tube were vortexed and poured onto bottom-agar plates containing Vogel-Bonner Minimal E 
(VBME) medium, and plates were incubated at 37°C for 3 days (72 h), after which the 
colonies were counted using an automatic colony counter (ProtoCOL 3, Synbiosis, 
Frederick, MD, USA). Data were stored automatically in an Excel spreadsheet on the 
ProtoCOL3. Ten percent of the aliquots had replicate samples (identical urines that were 
divided into two sample tubes) and were analyzed according to the methods described 
herein. Method blanks were included per batch of experiments with an average ± standard 
deviation of 0.9 ± 0.3 ml-equivalents of urine/plate.
As described in Mutlu et al. (2015), TA98 [hisD3052 chl-1008 (bio uvrB gal) rfa-1004 
pKM101+, Fels-1+, Fels-2+ Gifsy-1+ Gifsy-2+] detects frameshift mutagens (Mutlu et al. 
2015). We used YG1041, a derivative of TA98 that over-expresses nitroreductase and 
acetyltransferase, permitting it to detect frameshift mutagens that are nitroarenes or aromatic 
amines. A previous study (Kato et al. 2004b) of wood smoke-associated urinary 
mutagenicity in charcoal workers in Brazil showed that strain YG1041 + S9 was the most 
sensitive detector of such mutagenicity. Likewise, this strain was the most sensitive among 
the strains used to evaluate the mutagenicity of PM10 from wildland fires in Brazil (de 
Oliveira Galvao et al. 2018). Thus, we used the same strain with S9 for this study.
A negative or solvent control (DMSO at 100 μl/plate) and two positive controls (2-
nitrofluorene at 3 μg/plate and 2-aminoanthracene at 0.5 μg/plate) were included with each 
experiment (Note: The mean of seven batches of experiments that were conducted for the 
DMSO control for YG1041 +S9 was 60 revertants (rev)/plate, while the mean of the seven 
batches of experiments for 2-nitrofluorene for YG1041 −S9 and 2-aminoanthracene for 
YG1041 +S9 were 1715 and 1634 rev/plate, respectively). Three plates were used for each 
type of control for each experiment, and extracts were tested between 0.0 and 10.0, 0.0 and 
12.0, or 0.0 and 15.0 ml-eq/plate with four to seven doses per sample depending on the 
volume of urine sample available. Due to limited urine volumes, only one independent 
experiment for each extract per one plate/dose was conducted. A positive mutagenic 
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response was defined as a dose-related response with a twofold or greater increase in 
revertants (rev)/plate relative to the DMSO control plates. Urinary values were also 
creatinine-adjusted and reported as rev/μmole creatinine.
Statistical Analysis
Linear regressions over the linear portions of the dose-response curves were performed for 
all samples to determine the mutagenic potencies (expressed as rev/ml-eq). This included 
samples that did not approach a twofold increase over the solvent control and would 
otherwise be considered as a negative mutagenic response so that we could determine cross-
work shift changes in mutagenicity that included these samples. However, a few urine 
samples showed clear cytotoxicity (n = 9 of the 150 analyzed), as evidenced by negative 
slopes of the linear regressions. These sample values were disregarded in determining cross-
work shift changes and in the final statistical analyses because they were indicative of clear 
cytotoxicity and therefore mutagenicity was unmeasurable.
Heteroscedasticity and normality of the data were assessed for all variables. Log-
transformations were applied to normalize the variables, including time-weighted averages 
of PM2.5 concentration, CO concentration, absorption coefficient (surrogate for black 
carbon), MDA concentration, 8-isoprostane concentration, OH-Pyrene concentration, and 
urinary mutagenicity data. Note that to achieve normality, mass absorption efficiencies 
(surrogate for black carbon/PM2.5 ratio) were arcsine-square root transformed. The results of 
the statistical analysis were back-transformed.
We assessed cross-work shift (pre- to post-; and pre- to morning-after) changes in urinary 
mutagenicity by day type (burn and non-burn day) and by work task (holding, lighting, non-
burn day exposure, and non-burn day office), while also evaluating possible associations 
with the exposure measures including PM2.5, CO, absorption coefficient, mass absorption 
efficiency, and inhaled dose of PM2.5.
The approach used to estimate inhaled dose of PM2.5 has been reported previously (Adetona 
AM 2016). Briefly, accelerometer activity measurements recorded by the MicroPEM were 
used to estimate minute ventilation rate (L/min) using the linear regression equation 
published by Rodes et al. (i.e., V = m x ACCEL + b, where V is ventilation rate, m is the 
experimentally determined slope, ACCEL is the composite variable computed from the 
triaxial accelerometer measurements, and b is the intercept) (Rodes et al. 2012). Next, 
inhaled mass of PM2.5 (μg) was calculated by multiplying PM2.5 exposure concentrations by 
the total volume of inhaled air, which was estimated by multiplying the ventilation rate by 
the length of the monitoring period (Adetona AM 2016). Inhaled PM2.5 dose (μg/kg body 
weight) was then calculated by dividing the inhaled mass of PM2.5 by the subjects’ body 
weight (Adetona AM 2016).
Cross-work-shift changes in other outcomes, MDA, 8-isoprostane, and OH-Pyrene, 
according to day type and work task were also individually evaluated in a similar manner. 
Associations between urinary mutagenicity and the other outcomes, MDA, 8-isoprostane, 
and OH-Pyrene, were explored using the same statistical approach. To account for 
longitudinal within-subject correlations of the data, we included subject and date as random 
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effect variables in the model. Using the forward-stepwise procedure, we also tested for the 
effects of possible confounding factors such as smokeless tobacco used (chew), grilled-
foods, age, length of firefighter career, work-shift duration, and days since last prescribed 
burn. Only significant covariates were included in the final model.
Cross-work-shift changes are reported as post-work-shift/pre-work-shift ratios or morning-
after-work-shift/pre-work-shift ratios, respectively. Therefore, cross-work-shift ratios were 
statistically different if the mean ratios’ corresponding 95% confidence limits (95% CL) did 
not include the value of 1. Descriptive statistics and linear mixed-effect models were 
conducted using SAS v.9.4 (SAS Institute, Cary, NC, USA). Statistical significance was set 
at p< 0.05, and the Bonferroni method was used for multiple comparisons.
RESULTS
A total of 201 spot urine samples were collected throughout the study period. One sample 
was spilled during analytical procedures and therefore could not be analyzed. Thus, 48 
person-day paired (pre-post) samples were collected from 12 subjects on 7 prescribed burn 
days. We also collected 19 person-day paired (pre-post) samples from 8 subjects on 3 non-
burn working days during the season. In addition, we collected morning after (MA) work 
day samples, resulting in 40 person-day paired (pre-post-MA) samples on burn days and 16 
person-day paired (pre-post-MA) samples on non-burn days. Because some study 
participants were unable to give urine samples from time to time, there were a few occasions 
(6 in total) in which the MA in the sample set (pre, post, MA) was not completed, and these 
were not included in the person-day samples noted above.
Study population characteristics were described previously (Adetona AM 2016). In brief, the 
average age of the twelve subjects (nine men and three women) who participated in the 
study was 33 ± 5.4 years with subjects having less than 1 year to 22 years of experience as 
wildland firefighters. All subjects were non-smokers, although three subjects reported 
occasionally chewing smokeless tobacco. On average, 280 acres (Range: 38-1000 acres) 
were burned per day, and the duration of work-shifts averaged 4.5 h (Range: 1.9-9.4 h) on 
burn days and 6.2 h (Range: 3.9-7.8 h) on non-burn work days. The average PM2.5 and CO 
concentrations were 35.1 [95% CL: 15.9, 77.3] μg/m3 and 0.005 [95% CL: 0.002, 0.016] 
ppm, respectively, on non-burn work days, and 259.4 [95% CL: 156.1, 431.1] μg/m3 and 0.8 
[95% CL: 0.4, 1.8] ppm, respectively, on burn days (Adetona AM 2016). Unadjusted 
arithmetic and geometric means of crude and creatinine-corrected urinary mutagenicity, 
MDA, and 8-isoprostane, and OH-Pyrene concentrations according to day type and time of 
sample collection are presented in Table 1. The number of days between the last prescribed 
burn and sample collection was from 3 to 30 days and from 1 to over 30 days for non-burn 
and burn day assessments respectively. Urinary creatinine values were between 10 and 382 
mg/dL with 92% of the samples above the lower end of the normal range (30-300 mg/dL).
Cross-work Shift Changes in Urinary MutagenicityPercent positive results for mutagenicity 
and corresponding unadjusted arithmetic and geometric means by day type and time of 
sample collection are presented in Table 2. Twenty-eight percent of the post-work shift 
samples (14 of 50) on burn days were positive for mutagenicity, compared to 20% positive 
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post-work shift samples (4 of 20) on non-burn work days (Table 2). Unadjusted means 
(95%CL) for crude and creatinine-corrected post-work shift urinary mutagenicity levels on 
burn days were 7.7 (95% CL: 4.2, 11.2) (arithmetic) rev/mL-eq and 0.83 (95% CL: 0.19, 
1.48) (arithmetic) rev/μmol creatinine, and ranged from 4.4 to 28.0 rev/mL-eq and 0.24 to 
4.46 rev/μmol creatinine, respectively (Table 2). On non-burn work days, unadjusted mean 
crude and creatinine-corrected post-work shift urinary mutagenicity levels were 4.8 (95% 
CL: 3.6, 5.9) (arithmetic) rev/mL-eq and 0.33 (95% CL: 0.19, 0.46) (arithmetic) rev/μmol 
creatinine, and ranged from 4.2 to 5.8 rev/mL-eq and 0.22 to 0.41 rev/μmol creatinine, 
respectively (Table 2).
Adjusted cross-work shift (pre- to post-, and pre- to MA) changes in crude and creatinine-
adjusted urinary mutagenicity according to day type are presented in Figures 1 (a–d). No 
statistically significant effect of day type on cross-work shift (pre- to post- or pre- to MA) 
changes in crude or creatinine-adjusted mutagenicity was observed (p> 0.05). However, data 
trended in the expected direction, with slightly higher (though not significant) cross-work 
shift creatinine-adjusted change observed on burn days compared to non-burn work days 
(1.0 [95% CL: 0.6, 1.6 and 0.6 [95% CL: 0.5, 1.3], respectively) (Figure 1b). Likewise, pre- 
to MA cross-work shift changes in creatinine-adjusted mutagenicity also trended in similar 
directions, with burn days having 1.4 times higher cross-work shift (pre- to MA) increases 
compared to non-burn work days (1.1 [95% CL: 0.5, 2.2] and 0.8 [95% CL: 0.3, 1.9], 
respectively) (Figure 1d).
Adjusted cross-work shift (pre- to post-, and pre- to MA) changes in crude and creatinine-
adjusted urinary mutagenicity according to work tasks are presented in Figures 2 (a–d). 
Although lighters appeared to have the highest cross-work shift (pre- to post-) increase in 
urinary mutagenicity and were 1.6-fold higher compared to holding, no significant 
difference was observed between the two (p = 0.1487) (1.6, [95% CL: 1.0, 2.7] and 1.0 [95% 
CL: 0.5, 1.9], respectively) (Figure 2a). Likewise, no significant difference was seen 
between lighting and non-burn day exposures (p = 0.0901) (1.6, [95% CL: 1.0, 2.7] and 0.8 
[95% CL: 0.4, 1.8], respectively) (Figure 2a). No significant overall effect of work task was 
seen among crude or creatinine-adjusted cross-work shift (pre- to post- [Figures 2a and 2b] 
and pre- to MA [Figures 2c and 2d]) changes.
Cross-work Shift Changes Urinary Concentrations of MDAUnadjusted geometric mean 
crude and creatinine-adjusted post-work shift changes in MDA on burn days were 894.6 
(95% CL: 748.5, 1069.0) nmole/l and 84.3 (95% CL: 74.9, 95.0) μmol MDA/mole 
creatinine, and ranged from 175.3 and 3415.5 nmole/l and 37.1 and 212.5 μmol MDA/mole 
creatinine, respectively (Table 1). On non-burn work days, unadjusted geometric mean crude 
and creatinine-adjusted post-work shift changes in MDA were 828.6 (95% CL: 592.5, 
1158.9) nmole/l and 98.6 (95% CL: 77.5, 125.5) μmol MDA/mole creatinine, and ranged 
from 4225.4 and 4533.4 nmole/l and 37.1 and 212.5 μmol MDA/mole creatinine, 
respectively (Table 1).
Adjusted cross-work shift (pre- to post-, and pre- to MA) changes in crude and creatinine-
adjusted MDA according to day type are presented in Figures 3 (a–d). No significant 
difference was observed between cross-work shift changes on burn day and non-burn days 
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(Figures 3a, 3b, and 3d). However, a marginally significant difference in pre- to MA work 
shift crude MDA changes was observed between day types (p = 0.0502) (Figure 3c), with 
non-burn days having a higher crude MDA cross-work shift (pre- to MA) increase compared 
to burn days (1.7 [95% CL: 1.1, 2.7] and 1.1 [95% CL: 0.8, 1.5], respectively).
Adjusted cross-work shift (pre- to post-, and pre- to MA) changes in crude and creatinine-
adjusted MDA according to work tasks are presented in Figures 4 (a–d). No significant 
effect of work tasks was observed across all cross-work shift changes (Figures 4a–d); 
however, non-burn work day exposures showed marginally significant higher crude MDA 
cross-work shift (pre- to MA) changes compared to lighting (p = 0.0565) (1.8 [95% CL: 1.1, 
3.0] and 1.1 [95% CL: 0.8, 1.6], respectively) (Figure 4c).
Association between Urinary Mutagenicity, Oxidative Stress, and ExposureWe found 
positive correlations between cross-work shift (pre- to post) changes in urinary mutagenicity 
and MDA (p = 0.0010) (Figure 5), and between cross-work shift (pre- to post-) changes in 
urinary mutagenicity and OH-Pyrene (p = 0.0001) (Figure 6). Additionally, a positive 
relationship, though not significant, was observed between cross-work shift (pre- to post-) 
changes in urinary mutagenicity and mass absorption efficiency (surrogate for BC/PM2.5 
ratio) (p = 0.2245) (Figure 7).
No significant correlation was found between the remaining outcomes variables (PM2.5, 
inhaled dose of PM2.5, absorption coefficient) and cross-work shift changes in urinary 
mutagenicity, nor between the remaining exposure measures (PM2.5, inhaled dose of PM2.5, 
CO, absorption coefficient, and mass absorption efficiency (results not shown). Lastly, we 
found no significant effects for age; wildland firefighter career length; work-shift duration, 
days since last prescribed burn; use of smokeless tobacco (chew); or grilled foods on cross-
work shift changes in MDA, 8-isoprostane, or urinary mutagenicity (results not shown).
DISCUSSION
Constituents of wood smoke and non-wood smoke occupational exposures such as diesel 
exhaust and wood smoke during wildland firefighting are mutagenic and carcinogenic 
(IARC 2010, 2014; Adetona O et al. 2015; Adetona O et al. 2016; IARC 2016). A prior 
study of wildland firefighters found measurably higher urinary metabolites of OH-PAHs 
after occupational exposure, indicating that subjects received an internal dose of exposure to 
possible mutagenic and carcinogenic PAHs (Adetona O et al. 2015). Because firefighters are 
exposed to a mixture of pollutants throughout a given work day and receive cumulative 
exposures throughout the length of their career, it was necessary to find an integrated 
approach in assessing internal (systemic) dose to smoke constituents in this population. 
Therefore, we explored the use of urinary mutagenicity in Salmonella YG1041 +S9 among 
firefighters working at prescribed burns and during non-burn work days.
Our results are comparable to the values reported in the literature (Kato et al. 2004b; Long et 
al. 2014). However, we observed generally lower geometric means for pre-, post- and MA- 
work shift creatinine-adjusted urinary mutagenicity (positive results) among our study 
subjects compared to the geometric means reported among non-smoking charcoal workers 
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exposed to wood smoke in Brazil. Our burn day pre-work shift creatinine-adjusted urinary 
mutagenicity levels were 2.8× less than levels observed among the no-wood-smoke exposure 
group reported in Kato et al. (2004); and our burn day post-work shift and morning after-
work shift levels were 4.6× and 4.1× less, respectively, compared to the low-wood-smoke 
exposure group reported by Kato et al. (Kato et al. 2004b). Personal or ambient exposure 
monitoring, i.e., PM2.5 or CO levels, was not measured in the charcoal study; rather, subjects 
were grouped based on task-related exposure levels (Kato et al. 2004b). However, it is 
possible that exposures in Kato et al. may have been significantly higher compared to our 
study. Exposures in our current study were among the lower levels measured among 
firefighters. This could have been due to the changes in prescribed burn operations that 
reduced both the size and period of burns conducted compared to historical data (Adetona O 
2011; Adetona O, Simpson, et al. 2013; Hejl et al. 2013).
We found a non-significant 1.6-fold higher creatinine-adjusted urinary mutagenicity cross-
work shift change on burn days compared to non-burn day samples. These results are in the 
expected direction and are consistent with previous findings reported in the literature. For 
instance, Kato et al. (2004) found that charcoal workers exposed to wood smoke had 
prevalence odds ratios of 2.33 (95% CL: 0.83, 6.57) for urinary mutagenicity at low-wood-
smoke exposure levels and 5.31 (95% CL: 1.85, 15.27) at high-wood-smoke exposure levels 
compared to the non-exposed group of workers (Kato et al. 2004b). Likewise, another study 
on individuals from Mayan families from Guatemala (n = 32) who regularly used woodfired 
temazcales (steam baths) found that post-exposure samples were on average 1.7 times higher 
in urinary mutagenic potency compared to pre-exposure samples and also compared to 
control samples (n = 9, unexposed individuals from the same population)(Long et al. 2014).
In a study of occupational exposures to combustion emissions among structural firefighters, 
mutagenicity was assessed in urine collected before and after a fire event (Keir et al. 2017). 
Event-related increases in urinary mutagenicity were 4.3-fold higher in post-urine samples 
(Keir et al. 2017). One reason why our results may have differed compared to this study may 
be due to different levels of exposures to mutagenic compounds. Moreover, the PM2.5 
exposure levels reported in our present study were at least 2 times lower compared to studies 
conducted at the same site and elsewhere (Reinhardt and Ottmar 2004; Adetona O, Simpson, 
et al. 2013; Hejl et al. 2013).
Our data suggest that lighters may have higher cross-work shift increases in crude urinary 
mutagenicity compared to other work tasks (Figure 2a). These results are understandable in 
that firefighters who light fires may be exposed to diesel and wood smoke particulate matter 
and, therefore, may have an additive or perhaps synergistic systemic dose to mutagenic 
compounds (Mutlu et al. 2015). A recent experimental study found that extractable organic 
material (EOM) from diesel exhaust particles had significantly 50-85% higher mutagenic 
potency compared to extracts from soy-biodiesel emission particles (Mutlu et al. 2015).
We found no significant effect of day type or work task on cross-work shift (pre- to post-) 
changes in MDA. However, we found a marginally significant higher cross-work shift (pre- 
to MA) increase in cross-work shift changes in crude MDA on non-burn days compared to 
burn days (Figure 3c), and a marginally significant higher cross-work shift (pre- to MA) 
Adetona et al. Page 11
Inhal Toxicol. Author manuscript; available in PMC 2019 July 12.
EPA A
uthor M
an
u
script
EPA A
uthor M
an
u
script
EPA A
uthor M
an
u
script
increase in crude MDA for non-burn work day tasks that may have had other associated 
work exposures (Figure 4c). These results may be due to non-reported exposures on non-
burn days. For instance, MDA levels in the body may be impacted by diet, such as lipid-rich 
foods (Richelle et al. 1999; Bloomer et al. 2010). For example, a human cross-over study 
among young healthy men (n = 9) found increased MDA blood levels after eating heavy 
whipping cream (Bloomer et al. 2010).
Our unadjusted creatinine-MDA concentrations are comparable to a similar study on 
wildland firefighters exposed to wood smoke (Our study: Unadjusted pre- and post- work 
shift arithmetic mean creatinine-adjusted MDA [95% CL]: 105.6 [95% CL: 82.3, 128.8] and 
92.0 [95% CL: 80.5, 103.5], respectively [Table 1]; Adetona et al. (2013): Unadjusted pre- 
and post- work shift arithmetic mean creatinine-adjusted MDA ± SD: n=104, 88.14 ± 48.59 
μmol MDA/mole creatinine and n=96, 107.35 ± 33.90 μmol MDA/mole creatinine, 
respectively) (Adetona O, Zhang, et al. 2013). Similarly, our unadjusted exposure 
concentrations are comparable to this study’s reported corresponding unadjusted geometric 
mean PM2.5 and CO exposure concentrations of 248 (n = 82, 95% CL: 184, 333) μg/m3 and 
1.0 (n = 78, 95% CL: 0.07, 13) ppm, respectively (Adetona O, Zhang, et al. 2013). Also, 
similar to our study’s findings, no significant cross-work shift changes were observed for 
MDA in the urine samples of firefighters in the study of Adetona et al. (2013) (Adetona O, 
Zhang, et al. 2013). In contrast, results from a human chamber study found measurable 
increases in exhaled breath MDA levels after subjects were exposed to wood smoke 
(Barregard et al. 2008). (However, it is known that urinary MDA and exhaled breath MDA 
are not necessarily correlated (Gong et al. 2013)). We did not observe any significant cross-
work shift changes in urinary 8-isoprostane. Although Keir et al. observed increases in 
urinary mutagenicity after structural fire events, they did not find significant cross-work shift 
changes in urinary 8-isoprostane levels (Keir et al. 2017).
We found a marginally significant correlation between adjusted cross-work shift (pre- to 
post-) changes in creatinine-adjusted urinary mutagenicity and cross-work shift (pre- to 
post-) changes in creatinine-adjusted MDA (Figure 5). This association is plausible because 
MDA is potentially mutagenic (Hartman 1983; Niedernhofer et al. 2003). MDA may act as 
an endogenous genotoxic product of lipid peroxidation of polyunsaturated fatty acids in the 
body (Niedernhofer et al. 2003). An in vitro study evaluated the mutagenic potential of 
MDA in human cells and found that MDA induced a 15-fold increase in mutation frequency 
in the supF reporter gene compared with untreated DNA (Niedernhofer et al. 2003). MDA 
induced multiple types of mutations, including large insertions and deletions (most 
frequently), base pair substitutions, and inter-strand cross-links (Niedernhofer et al. 2003).
Although urinary mutagenicity was not associated with PM2.5 exposure or inhaled dose of 
PM2.5, it was correlated with exposure to components of particulate matter. A significant 
correlation was observed between adjusted cross-work shift (pre- to post-) changes in 
creatinine-adjusted urinary mutagenicity and OH-Pyrene exposure (Figure 6). Various PAHs, 
found in wood smoke and diesel exhaust, are potentially mutagenic and carcinogenic (Kato 
et al. 2004b). Results from Kato et al. showed that urinary mutagenicity increased 
significantly after wood smoke exposure and was modified by smoking among 154 Brazilian 
charcoal workers (prevalence odds ratio of highly exposed workers versus non-exposed: 5.31 
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[95% CL: 1.85, 15.27]) (Kato et al. 2004b). Furthermore, the study reported significantly 
higher levels of 2-Naphthol and OH-Pyrene among the highly exposed group compared to 
the non-exposed (Kato et al. 2004b). Higher PAH exposures were also observed in structural 
firefighters with higher urinary mutagenicity levels (Keir et al. 2017).
Increased cross-work shift mutagenicity on non-burn days observed for some subjects could 
have been due to their exposures to mutagenic compounds. Some of the subjects reported 
performing tasks at which they could have experienced mutagenic exposures such as exhaust 
from engines, smoke from smoldering when patrolling areas where recent burns were 
conducted, or dust during field-prep work (Adetona AM 2016). In addition, exposures of a 
few subjects during the work-shift on non-burn days to OH-PAHs was apparent as indicated 
by their large increase in OH-Pyrene excretion across the work-shift (Figure 6).
We also observed a positive (though not significant) correlation between cross-work shift 
(pre- to post-) changes in creatinine-adjusted urinary mutagenicity and mass absorption 
efficiency (surrogate for BC/PM2.5 ratio) (Figure 7). This relationship suggests that urinary 
mutagenicity is dependent on the type of particles and composition of PM, i.e., BC content. 
Firefighters lighting with diesel-gasoline fueled drip-torches appear to have higher urinary 
mutagenicity as depicted in Figure 7 and suggested in Figure 2a. A previous study using 
extracted particles from diesel engine exhaust, which has a higher BC proportion compared 
to wood smoke, (Naeher et al. 2007; Ris 2007) had a higher mutagenic potency compared to 
soy-biodiesel particles (Mutlu et al. 2015).
Limitations
This study was a pilot study exploring the use of urinary mutagenicity among wildland 
firefighters, and the study sample size was powered initially using an effect size for a 
different health endpoint estimated from a previous piloted study (Hejl et al. 2013). 
Increasing the sample size in follow up studies will be important to determine small effects 
and ability to dissociate the effect of confounders. MDA could be influenced by dietary 
intake of high-lipid content foods. Biomarkers of lipid peroxidation that were not affected by 
lipid intake, such as urinary isoprostanes (Richelle et al. 1999), may be used as an alternative 
in future studies. Additionally, occupational exposures observed in this study were relatively 
low. Future studies should investigate mutagenicity at higher exposure levels because there 
was an association with particulate matter components in this study, and wood smoke is 
mutagenic (Kato et al. 2004b; Kim et al. 2018). Although our study was a repeated measures 
study design where subjects’ served as their own controls, inclusion of a non-exposed 
control group in the future would be valuable because wildland firefighters often perform 
various tasks on non-burn days that may result in inadvertent exposures to pollutants.
CONCLUSION
Results from this study suggest that healthy, non-smoking wildland firefighters are exposed 
to genotoxic compounds during prescribed burning. Urinary mutagenicity may serve as a 
suitable measure of occupational smoke exposures among this worker population when 
exposure levels are likely higher than what was observed in this study. No statistically 
significant cross-work shift increases were observed in creatinine-adjusted urinary 
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mutagenicity between burn and non-burn days. However, our results suggest that firefighters 
using drip-torches to light fires have potentially higher urinary mutagenicity during 
prescribed burns than during other work tasks. Findings from this study suggest that 
occupational smoke exposure, especially related to tasks involving lighting fires on 
prescribed burns, may contribute to systemic exposure to mutagens.
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Figures 1(a-d). Adjusted Cross-Work Shift Changes in Crude and Creatinine-adjusted Urinary 
Mutagenicity Concentrations according to Day Type.
Pre- to post-work shift changes are depicted in Figs. 1a and 1b. Pre to morning-after (MA) 
work shift changes are depicted in Figs. 1c and 2d. No significant difference was observed 
between burn day and non-burn day samples for all figures. Note: n= person-day pre-post 
paired or pre-MA paired samples, respectively; Cross-work-shift changes are reported as 
post-work-shift/pre-work-shift ratios or morning-after-work-shift/pre-work-shift ratios, 
respectively. Where 95% confidence limits do not cross the x-axis, cross-work-shift changes 
are statistically different from 1 (p-values < 0.05).
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Figures 2(a-d). Adjusted Cross-Work Shift Changes in Crude and Creatinine-adjusted Urinary 
Mutagenicity Concentrations according to Work Tasks.
Pre-to post-work shift changes are depicted in Figs. 2a and 2b. Pre to morning-after (MA) 
work shift changes are depicted in Figs. 2c and 2d. No significant difference was observed 
across work tasks for all figures. Note: n= person-day pre-post paired or pre-MA paired 
samples, respectively; Cross-work-shift changes are reported as post-work-shift/pre-work-
shift ratios or morning-after-work-shift/pre-work-shift ratios, respectively. Where 95% 
confidence limits do not cross the x-axis, cross-work-shift changes are statistically different 
from 1 (p-values < 0.05).
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Figures 3(a-d). Adjusted Cross-Work Shift Changes in Crude and Creatinine-adjusted Urinary 
Malondialdehyde Concentrations according to Day Type.
Pre- to post-work shift changes are depicted in Figs. 3a and 3b. Pre to morning-after (MA) 
work shift changes are depicted in Figs. 3c and 3d. No significant difference was observed 
between burn day and non-burn day samples for Figs. 3a, 3b, or 3d, however marginal 
significant differences were observed in Fig. 3c (p-value <0.05 was considered significant). 
Note: n= person-day pre-post paired or pre-MA paired samples, respectively; Cross-work-
shift changes are reported as post-work-shift/pre-work-shift ratios or morning-after-work-
shift/pre-work-shift ratios, respectively. Where 95% confidence limits do not cross the x-
axis, cross-work-shift changes are statistically different from 1 (p-values < 0.05).
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Figures 4(a-d). Adjusted Cross-Work Shift Changes in Crude and Creatinine-adjusted Urinary 
Malondialdehyde Concentrations according to Work Tasks.
Pre-to post-work shift changes are depicted in Figs. 4a and 4b. Pre to morning-after (MA) 
work shift changes are depicted in Figs. 4c and 4d. No significant difference was observed 
across work tasks for all figures. Note: n= person-day pre-post paired or pre-MA paired 
samples, respectively; Cross-work-shift changes are reported as post-work-shift/pre-work-
shift ratios or morning-after-work-shift/pre-work-shift ratios, respectively. Where 95% 
confidence limits do not cross the x-axis, cross-work-shift changes are statistically different 
from 1 (p-values < 0.05).
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Figure 5. Correlation between Log-transformed Cross-Work Shift (Pre- to Post-) Changes in 
Creatinine-adjusted Urinary Mutagenicity and Log-transformed Creatinine-adjusted MDA.
Person days are indicated as n. Linear mixed effect model results showed a positive 
significant correlation (p = 0.0010).
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Figure 6. Correlation between Log-transformed Cross-Work Shift (Pre- to Post-) Changes in 
Creatinine-adjusted Urinary Mutagenicity and Log-transformed Creatinine-adjusted OH-
Pyrene.
Person days are indicated as n. Linear mixed effect model results showed a positive 
significant correlation (p = 0.0001).
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Figure 7. Correlation between Arcsine-square root Transformed Mass Absorption Efficiency 
(Surrogate for Black Carbon/PM2.5 Ratio) and Log-transformed Cross-Work Shift (Pre- to 
Post-) Changes in Creatinine-adjusted Urinary Mutagenicity.
Person days are indicated as n. Linear mixed effect model results showed a cluster of data by 
work task and a positive (though not significant) correlation (p=0.2245).
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Table 2.
Percent Positive Results for Mutagenicity and Corresponding Unadjusted Arithmetic and Geometric Means by 
Day Type and Time of Sample Collection
Day Type
Sample Collection Time
Pre-Work Shift Post-Work Shift Morning-after Work Shift
Burn Day
Number and Percent Positive for Mutagenicity, n of total, % 9 of 50 18% 14 of 50 28% 10 of 43 23%
Unadjusted Arithmetic Means (95%CL)
 Crude Urine Mutagenicity (rev/ml-eq) 8.4 (3.3, 13.5) 7.7 (4.2, 11.2) 7.8 (5.5, 10.0)
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.44 (0.20, 0.68) 0.83 (0.19, 1.48) 0.63 (0.39, 0.88)
Unadjusted Geometric Means (95%CL)
 Crude Urine Mutagenicity (rev/ml-eq) 6.8 (4.1, 11.2) 6.7 (5.1, 8.8) 7.3 (5.5, 9.6)
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.37 (0.24, 0.58) 0.55 (0.34, 0.88) 0.56 (0.39, 0.81)
Ranges (Min, Max)
 Crude Urine Mutagenicity (rev/ml-eq) 3.7, 23.6 4.4, 28.0 4.6, 13.6
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.20, 1.16 0.24, 4.46 0.32, 1.41
Non-Burn Day
Number and Percent Positive for Mutagenicity, n of total, % 3 of 20 15% 4 of 20 20% 4 of 18 22%
Unadjusted Arithmetic Means (95%CL)
 Crude Urine Mutagenicity (rev/ml-eq) 5.9 (2.5, 9.4) 4.8 (3.6, 5.9) 7.4 (6.1, 8.6)
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.61 (−0.29, 1.50) 0.33 (0.19, 0.46) 0.55 (0.30, 0.79)
Unadjusted Geometric Means (95%CL)
 Crude Urine Mutagenicity (rev/ml-eq) 5.8 (3.2, 10.7) 4.7 (3.7, 6.0) 7.3 (6.1, 8.7)
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.54 (0.11, 2.57) 0.32 (0.20, 0.49) 0.53 (0.34, 0.84)
Ranges (Min, Max)
 Crude Urine Mutagenicity (rev/ml-eq) 4.5, 7.3 4.2, 5.8 6.3, 8.0
 Creatinine-corrected Urine Mutagenicity (rev/μmole creatinine) 0.28, 1.00 0.22, 0.41 0.37, 0.74
Note: n= person-day samples; Revertants/ml-equivalent of urine (rev/ml-eq); 95% Confidence Limits (95%CL).
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